NCT Number: NCT02991300
BioPoly® RS Partial Resurfacing Patella Registry Study
The data registry will increase the knowledge of outcomes for treatment of focal cartilage defects of the patella treated with the BioPoly RS Patella Implant and will allow monitoring of the clinical safety and performance of the device and surgical implantation kit
Looking for future studies?
Notify MeKey information
Conditions
Age range
21 year and older
Sex eligibility
All sexes
Study type
Observational
Primary location
Charing Cross Hospital, London, England, United Kingdom
About this study
The data registry will increase the knowledge of outcomes for treatment of focal cartilage defects of the patella treated with the BioPoly RS Patella Implant This study will also allow monitoring of the clinical safety and performance of the device and surgical implantation kit
Who can participate
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Age 21 years and older
- Cartilage lesion(s) located in the facets of the patella that have failed prior therapy (conservative or surgical)
- Symptomatic lesions classified as ICRS grade 2, 3, or 4
- Lesion size may not exceed 3.1 cm2 and must be circumscribed by a 15 mm or 20 mm circle of normal or nearly normal (ICRS Grade 0 or 1) cartilage, with an overall depth less than 4 mm from the articulating surface
- Subchondral bone quality sufficient to support the implant
- Understanding and willingness to comply with the post-operative rehabilitation instructions and follow-up visits.
Exclusion criteria
- Body mass index (BMI) ≥ 35
- Generalized degenerative or autoimmune arthritis
- Gout
- Uncorrected chronic malalignment of the patella (may be corrected at the same time as the implantation of the BioPoly device).
- Uncorrected ligamentous instability (may be corrected at the same time as the implantation of the BioPoly device).
- Kissing lesion on femur
- More than one implant required to accommodate lesion
- Allergy to ultra-high molecular weight polyethylene (UHMWPE), or hyaluronan/ hyaluronic acid (HA)
- Use with opposing articulating femoral components
- Any concomitant painful or disabling disease of the spine, hips, or lower limbs that would interfere with evaluation of the afflicted knee
- Pregnant, prisoner, vulnerable population, or unable to provide informed consent.
Treatment and study plan
Primary outcomes
-
KOOS Subscores
Time frame: 2 year post-op
KOOS
-
Kujala Anterior Knee Pain Scale
Time frame: 2 year post-op
Kujala
-
Medical Outcomes Study (SF-36) for generic "quality of life"
Time frame: 2 years post-op
SF-36
-
Activity using Tegner Score
Time frame: 2 years post-op
Tegner
-
Pain using VAS Pain
Time frame: 2 years post-op
VAS Pain
Secondary outcomes
-
Radiographic Assessment
Time frame: Annually through 5 years post-op
Radiographic Assessment
Sponsors and collaborators
Lead sponsor
BioPoly LLC
Industry
Registry information
Official study title
Open Label, Prospective, Consecutive Series Registry Database of BioPoly® RS Partial Resurfacing Patella Implant
Important dates
- Study start
- 2016
- Primary completion
- 2024
- Study completion
- 2024
- First posted
- Dec 13, 2016
- Registry last updated
- Apr 16, 2025
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
All Autologous Cartilage Regeneration in the Treatment of the Knee Cartilage Defects
NCT04785092
Cartilage Damage, Cartilage Disease
Bologna, Italy
View Trial DetailsObservational Study With NOVOCART® Inject in the Reconstruction of the Hip Joint With Full Thickness Cartilage Defects
NCT02179346
Cartilage Disease, Cartilage Diseases
Dresden, Germany
View Trial DetailsNon-interventional Study With NOVOCART® Inject in the Reconstruction of the Knee Cartilage Defects
NCT02941120
Cartilage Disease, Cartilage Diseases
Bad Homburg, Germany
View Trial DetailsLong-term Outcome Evaluation of Patients Undergoing Autologous Chondrocyte Transplantation Delivered on Biomaterial
NCT06238947
Cartilage Disease, Cartilage Diseases
View Trial Details